BioSpace News Archive

Today, Sanofi and GSK announce the signing of agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted COVID-19 vaccine, beginning in 2021.

LUNGevity Foundation, the nation’s premier lung cancer-focused nonprofit organization, announced today that Maximilian Diehn, MD, PhD, has joined its Scientific Advisory Board.

At the onset of the pandemic the nation began to practice social distancing, and subsequently, many stopped scheduling visits with their doctors. Laboratories like Premier Medical Laboratory Services suddenly pivoted much of their efforts into providing a high volume of testing for COVID-19. Now, as more businesse

Humanigen, Inc., a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate lenzilumab™, announced that it has completed its previously announced underwritten public offering of common stock.

ARCpoint Labs offers free Webinar on Sept. 30, 2020 to help identify proper tests, safe ways to return to work and school.

Seventeen subjects with advanced cancer pain received epidural RTX (0.4 to 25 mcg). No dose limiting toxicities were reported. A majority of patients reported meaningful pain reduction of 30% or more from baseline. Sorrento expects to submit to the FDA a request to proceed with a Phase 3 clinical trial in this orphan indication imminently. SAN DIEGO, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced the public release of the results of it

Michael Einodshofer, RPh, MBA, Chief Pharmacy Officer at Maxor assumes role of Chairman of the Board for the National Association of Specialty Pharmacy

Wisconsin Pharmacal Company, LLC has announced that Andrew Wundrock has been appointed to the position of President of the company effective September 2020.

Predictive Oncology now has a total of 96 unique Patient Derived Cells (PDCs) from Ovarian Cancer Patients.

The Association for Value-Based Cancer Care (AVBCC) is proud to announce the highly esteemed Co-Chairs for the upcoming 10th Annual AVBCC Summit. As in years past, the Co-Chairs are a hand-selected powerhouse of leaders in the cancer care ecosystem. The Co-Chairs are intimately involved with the selection of more than 150 fa